Daniel Bradbury Net Worth & Insider Trades

Daniel Bradbury - Director, Intercept Pharmaceuticals, Inc

As of May 27, 2022

What is Daniel Bradbury's Net Worth?

The current estimated net worth of Intercept Pharmaceuticals, Inc's Director, Daniel Bradbury, is estimated to be about $82.72M . Daniel Bradbury owns about 11,642 units of Intercept Pharmaceuticals, Inc common stock. In the last 6 years at Intercept Pharmaceuticals, Inc, Daniel Bradbury has sold an estimated value of $0 worth.

What is Daniel Bradbury's Past Insider Trading?

Daniel Bradbury's largest purchase order was 7,812 units , worth over $499.97K on April 9, 2018. In total, Daniel Bradbury has made about 8 transactions over 6 years of their time at Intercept Pharmaceuticals, Inc. Daniel Bradbury usually trades in June, with the busiest year in 2018.

DANIEL BRADBURY

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Daniel Bradbury's' Mailing Address?

  • Mailing address is Biobrit, Llc 2223 Avenida de la Playa, Suite 108 La Jolla CA 92037 CA

Intercept Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark Pruzanski, M.D., 2020 $757,850 - $4,113,504 $1,015,996 $531,995 $7,660 $6,427,005
Mark Pruzanski, M.D., 2019 $734,292 - $4,197,742 $1,116,118 $560,265 $7,368 $6,615,785
Mark Pruzanski, M.D., 2018 $702,000 - $1,667,718 $1,705,358 $442,260 $8,623 $4,525,960
Jerome Durso, 2020 $599,524 - $2,057,016 $998,776 $231,737 $21,910 $3,908,963
Jerome Durso, 2019 $573,250 - $2,089,570 $1,238,321 $359,284 $21,368 $4,281,793
Jerome Durso, 2018 $540,800 - $1,554,326 $775,844 $292,032 $22,403 $3,185,406
Sandip Kapadia, 2020 $476,863 - $1,087,836 $528,088 $184,039 $21,910 $2,298,736
Sandip Kapadia, 2019 $464,100 - $1,001,664 $586,573 $252,935 $21,368 $2,326,640
Sandip Kapadia, 2018 $442,000 - $790,164 $393,544 $228,735 $22,403 $1,876,846
Richard Kim, 2020 $456,095 - $1,044,360 $505,128 $168,056 $79,211 $2,252,850
Richard Kim, 2019 $442,900 $202,800 $890,368 $521,398 $265,519 $76,343 $2,399,328
Lisa Bright, 2020 $480,552 - $925,704 $453,467 $240,955 $139,106 $2,239,784
Ryan Sullivan, 2020 $437,107 - $1,087,836 $528,088 - $89,942 $2,142,973
Ryan Sullivan, 2019 $445,520 - $1,471,902 $871,713 $267,089 $21,368 $3,077,592
Ryan Sullivan, 2018 $376,158 - $1,239,112 $1,190,351 $229,122 $173,437 $3,208,180
Christian Weyer, M.D., M.A.S., 2020 $486,731 - $925,704 $453,467 $170,804 $21,910 $2,058,616
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1270073/000110465921055639/tm218121-2_def14a.htm

What are Intercept Pharmaceuticals, Inc's Past Insider Trades?

Intercept Pharmaceuticals, Inc's most recent insider trade came on March 12, 2021 by Srinivas Akkaraju who bought 237,000 units worth $5.02M . In the last 9 years, insiders at Intercept Pharmaceuticals, Inc have sold an estimated value of $1.66B and bought an estimated value of $148.73M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are David Shapiro, Chief Medical Officer,  Mark Pruzanski, Director,  and Lisa Bright, President .

INTERCEPT PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1